Loading
Distinct shells carrying a filed role for this person — not every shell they have ever touched.
Of those vehicles, the ones that closed a merger.
Announced but not closed, and still hunting.
No closed vehicle here has both a stored price and a filed trust value to score it against.
3 vehicles on file, newest listing first
1 of 10 appear on more than one · 1 vehicle carry no counterparty filing we have read
Jeff LeBlanc has served as a member of our Board since May 16, 2024. He is the Chief Financial Officer of Klotho Therapeutics Holdings, a biotechnology company focused on advancing treatments for neurodegenerative and kidney diseases. Mr. LeBlanc has more than 15 years of experience in corporate finance, strategy, and operations. We believe Mr. LeBlanc is well-qualified to serve on our Board due to his financial expertise and broad industry experience. Rainer Michael Preiss has served as a member of our Board since November 27, 2024. Mr. Preiss is a seasoned investment professional and wealth management advisor, with extensive experience in asset management and private banking. He has held senior positions at major global financial institutions and has provided strategic advisory services to sovereign wealth funds, family offices, and ultra-high-net-worth clients. Mr. Preiss is currently active as a senior advisor in the investment sector. We believe Mr. Preiss is well-qualified to serve on our Board due to his global financial expertise and leadership experience. Number and Terms of Office of Officers and Directors Our board of directors consists of four members. Our current sponsor appointed each of our directors or a two-year term, and holders of our public shares do not have the right to vote on the appointment of directors during such term.
This record is keyed to SEC CIK 0001854467 — the identifier this person files under in their own name. Every vehicle above is a filing made under that CIK, so “the same person on two shells” is a fact about an SEC identifier rather than about a name that happens to match.
Roles are the strings the filings used, in the order they were filed. Nothing on this page ranks them, infers seniority, or offers a reason why any two of these names recur — a recurrence is a count, and the filings that produced it are linked beside every row. We also hold 105 institutional-holder rows on these vehicles, under 47 distinct name strings, and none of them is counted across vehicles: that table has no CIK column, and matching holders by name would merge firms that are not the same firm.